Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Aviva faces margin pressure in pension risk transfer but RBC sees 24% upside potential.

Market News
18 May 2026
Proactive Investors
View Source
Neutral
pluang ai news

Aviva PLC's core insurance and wealth management businesses remain strong, with solid performance in UK and Canadian general insurance and a 49% rise in wealth net inflows. However, intense competition in the pension risk transfer (PRT) market is squeezing margins, causing Aviva's retirement margin to drop from 3.6% to 1.2%. RBC Capital Markets maintains an 'outperform' rating with a 770p price target, suggesting about 24% upside, but warns that PRT competition may worsen before improving, especially after recent industry takeovers. This dynamic impacts Aviva's profitability outlook but also signals potential growth opportunities in wealth management and AI-driven initiatives.

More News

Equinor awards shares to insiders under employee savings and long-term incentive programs.

Equinor awards shares to insiders under employee savings and long-term incentive programs.

On May 20, 2026, Equinor ASA allocated shares to certain primary insiders and their close associates as part of its employee share savings and long-term incentive programs. The shares were granted at a price of NOK 356.31 each under the long-term inc...

Company Fundamentals
Neutral
48 minutes ago
SalMar raises 2026 volume guidance by 12,000 tons after strong Q1 biological results and cost improvements.

SalMar raises 2026 volume guidance by 12,000 tons after strong Q1 biological results and cost improvements.

SalMar ASA reported a significant profit improvement in Q1 2026 driven by higher harvest volumes, better fish quality, and lower costs. Operational EBIT for Norway reached NOK 1,536 million with a harvest volume of 56,300 tons, while the group’s tota...

Company Fundamentals
Bullish
3 hours ago
SalMar raises 2026 volume guidance after record-strong biological performance in Q1.

SalMar raises 2026 volume guidance after record-strong biological performance in Q1.

SalMar ASA reported a significant improvement in Q1 2026 results, driven by higher harvest volumes, better fish quality, and lower costs. Operational EBIT for Norway reached NOK 1,536 million with a harvest volume of 56,300 tonnes. The company experi...

Company Fundamentals
Bullish
3 hours ago
Leqembi sales exceed €500M, triggering milestone; FDA extends review for subcutaneous use to Aug 2026

Leqembi sales exceed €500M, triggering milestone; FDA extends review for subcutaneous use to Aug 2026

BioArctic reported strong Q1 2026 results driven by Leqembi, an Alzheimer's drug co-developed with Eisai. Sales surpassed €500 million in Eisai's fiscal year 2025, triggering a €20 million milestone payment. The FDA granted Priority Review for Leqemb...

Company Fundamentals
Bullish
4 hours ago
Itafos trades at low valuation amid sulfur cost pressures impacting fertilizer margins.

Itafos trades at low valuation amid sulfur cost pressures impacting fertilizer margins.

Itafos, a phosphate fertilizer producer with a key facility in Idaho, faces margin pressures due to a sharp rise in sulfur costs relative to phosphate. Historically, sulfur-to-phosphate cost ratios were around 30%, but now exceed 130%, limiting the c...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App